Tirzepatide
A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Eli Lilly · Phase 1/2 · Active, not recruiting · Enrollment 190
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.